688767 Stock Overview
Engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Hangzhou Biotest Biotech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥30.92 |
| 52 Week High | CN¥36.70 |
| 52 Week Low | CN¥22.23 |
| Beta | 0.52 |
| 11 Month Change | 3.65% |
| 3 Month Change | 16.68% |
| 1 Year Change | -6.47% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688767 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.8% | -1.9% | -2.8% |
| 1Y | -6.5% | -21.0% | 2.0% |
Return vs Industry: 688767 exceeded the CN Biotechs industry which returned -19.8% over the past year.
Return vs Market: 688767 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 688767 volatility | |
|---|---|
| 688767 Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 9.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688767 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688767's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 611 | Shujiang Wu | www.biotests.com.cn |
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases.
Hangzhou Biotest Biotech Co.,Ltd. Fundamentals Summary
| 688767 fundamental statistics | |
|---|---|
| Market cap | CN¥3.23b |
| Earnings (TTM) | CN¥104.29m |
| Revenue (TTM) | CN¥518.65m |
31.0x
P/E Ratio6.2x
P/S RatioIs 688767 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688767 income statement (TTM) | |
|---|---|
| Revenue | CN¥518.65m |
| Cost of Revenue | CN¥289.19m |
| Gross Profit | CN¥229.46m |
| Other Expenses | CN¥125.17m |
| Earnings | CN¥104.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.00 |
| Gross Margin | 44.24% |
| Net Profit Margin | 20.11% |
| Debt/Equity Ratio | 0.01% |
How did 688767 perform over the long term?
See historical performance and comparison